Search clinical trials for: KC706

Total 7 results

Kemia, Inc

Completed

Use of KC706 for the Treatment of Pemphigus Vulgaris

Pemphigus Vulgaris

United States
Sun Pharma Advanced Research Company Limited

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of K0706 in Plasma and Cerebrospinal Fluid in Healthy Volunteers

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

Bioavailability Study of K0706 in Healthy Subjects

Healthy

United States
Sun Pharma Advanced Research Company Limited

Completed

Safety and Tolerability Study of K0706 in Subjects With Parkinson's Disease

Parkinson Disease

United States
Georgetown University
Sun Pharma Advanced Research Company Limited

Recruiting

K0706 for Patients Diagnosed With Dementia With Lewy Bodies

Dementia With Lewy Bodies

United States
Sun Pharma Advanced Research Company Limited

Active, not recruiting

PROSEEK: A Phase 2 Study In Early Parkinson's Disease Patients Evaluating The Safety And Efficacy Of Abl Tyrosine Kinase Inhibition Using K0706

Early Parkinson Disease

United States, Spain, India, Hungary, Slovakia, Poland
Sun Pharma Advanced Research Company Limited

Active, not recruiting

Safety and Anti-leukemic Activity of Vodobatinib (K0706) for Treatment of Ph+ CML Resistant/Intolerant to ≥3 Prior CML Therapies

Healthy (For Part A) | Chronic Myeloid Leukemia (for Part B and C)

United States, Spain, Hungary, Italy, India, Belgium, France, Romania, Singapore, United Kingdom, Korea, Republic of, Turkey

3

Subscribe